Amplify Weight Loss Drug & Treatment ETF
Amplify Holding Co. LLC THNR ETF
| THNR Price | $24.6593 |
Market Cap | $4.24M |
| Annual Dividend Yield | 1.66% |
Annual Dividend | $0.41 |
| Yearly Management Fee | 0.59% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Pharma, biotech & life sciences |
Last 24h Volume | $549 |
| Portfolio Management Company | Amplify Holding Co. LLC |
Discount/Premium to NAV | 0.20% |
| Inception Date | May 21, 2024 |
Market Cap Rank | 4631 |
| Monthly AUM Growth | -0.46% |
Holdings Region | Developed markets |
| Management Style | Passive |
Leverage | Non-Leveraged |
Amplify Weight Loss Drug & Treatment ETF is an ETF issued by Amplify Holding Co. LLC on May 21 2024.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of THNR ETF according to its net asset value is premiumed at 0.20%.
While the total value of the fund shows $-19,703 decrease compared to the previous month, its price is traded daily at a decrease of -1.04%.
The annual dividend yield of THNR ETF is 1.66%, whereas its main asset area is Developed markets.
THNR ETF, whose 24-hour total volume is $549, has experienced a $0 cash outflow in the last month.
In addition, Amplify Weight Loss Drug & Treatment ETF's one-year net asset value total return is 28.88%.
THNR ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -1.04% |
-0.45% |
-1.36% |
-5.78% |
0.77% |
-3.49% |
29.17% |
THNR ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| -0.73% |
-4.31% |
-1.25% |
28.88% |
11.84% |
11.84% |
THNR ETF Fund Flows Chart
THNR ETF Market Cap Chart
THNR ETF NAV Growth Chart
THNR ETF Comments
no comments yet